XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF RESERVED SHARES

At June 30, 2021, the Company has reserved 13,917,461 shares of authorized but unissued common stock for possible future issuance. At June 30, 2021, shares were reserved in connection with the following:

 

Exercise of outstanding stock options   4,133,856 
Exercise of outstanding stock warrants   9,540,187 
Conversion of outstanding Series Alpha preferred stock   243,418 
Total   13,917,461 
SCHEDULE OF STOCK OPTION ACTIVITY

The following represents a summary of the options granted (under the 2020 Plan and otherwise) to employees and non-employee service providers that are outstanding at June 30, 2021, and changes during the six-month period then ended:

 

    Shares     Weighted– Average
Exercise
Price
   

Range of Exercise

Price

    Weighted– Average Remaining
Life (Years)
 
Total outstanding – December 31, 2020     4,011,356     $ 7.05     $ 3.521,465.75       9.29  
Granted     127,000       2.12       1.803.29       9.83  
Expired                        
Forfeited     (4,500 )     3.68       3.524.97        
Total outstanding – June 30, 2021     4,133,856     $ 6.90     $ 1.801,465.75       8.82  
Exercisable (vested)     1,296,860     $ 11.50     $ 4.971,465.75       8.36  
Non-Exercisable (non-vested)     2,836,996     $ 4.80     $ 1.805.13       9.04  
SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES OPTION-PRICING METHOD

The material factors incorporated in the Black-Scholes model in estimating the fair value of the options granted for the periods presented were as follows:

 

   

For the six months
ended
June 30, 2021

 
Expected dividend yield     0.00 %
Expected stock-price volatility     102 %
Risk-free interest rate     0.84% — 1.18 %
Expected average term of options     6.0  
Stock price   $ 2.12  
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

 

   For the six months ended June 30, 
   2021   2020 
General and administrative  $2,201,499   $277,807 
Research and development   347,550    88,684 
Total  $2,549,049   $366,491 
Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes the activity in the common stock equity classified compensatory warrants received in exchange for the Series C convertible preferred stock equity classified compensatory warrants for the six months ended June 30, 2021:

 

    Common Stock  
    Shares    

Weighted–

Average

Exercise
Price

   

Range of Exercise

Price

    Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2020     1,294,217     $ 1.66                  
Common stock warrants received in exchange for Series C preferred stock warrants upon reverse recapitalization     -       -                  
Legacy Ritter warrants                            
Granted                            
Exercised     (38,390 )     2.09                  
Expired                            
Forfeited     (65,179 )     2.07                  
Total outstanding – June 30, 2021     1,190,648     $ 1.62                  
Exercisable     1,187,052     $ 1.62     $ 1.112.54       3.75  
Non-Exercisable     3,596     $ 2.54     $ 2.54       5.23  
  Common Stock  
    Shares    

Weighted–

Average

Exercise
Price

   

Range of Exercise

Price

   

Weighted– Average Remaining

Life (Years)

 
Total outstanding – December 31, 2019         $ 1.99                  
Common stock warrants received in exchange for Series C preferred stock warrants upon reverse recapitalization     668,024       2.34                  
Legacy Ritter warrants                            
Granted     811,431       1.11                  
Expired                            
Forfeited                            
Total outstanding – June 30, 2020     1,479,455     $ 1.67                  
Exercisable     660,832     $ 2.34     $ 2.072.54       3.82  
Non-Exercisable     818,623     $ 1.12     $ 1.112.54       4.91  
 
Non Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes the noncompensatory equity classified warrant activity for the six months ended June 30, 2021:

    Common Stock  
    Shares    

Weighted–

Average

Exercise
Price

   

Range of Exercise

Price

    Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2020     6,549,777     $ 4.37                  
Exercised     (1,000,000 )     0.01                  
Granted                            
Expired                            
Forfeited                            
Total outstanding – June 30, 2021     5,549,777     $ 5.15                  
Exercisable     5,549,777     $ 5.15     $ 1.11 2,325.00       1.33  
Non-Exercisable         $